Wellstat Therapeutics Corporation Grants BTG plc (BGC.L) European Distribution Rights to Investigational Antidote for 5-FU Overexposure
5/22/2012 12:20:31 PM
More...
|
Wellstat Therapeutics Corporation Grants U.S. Distribution Rights to its Investigational Antidote for 5-FU Overexposure to Specialist Healthcare Company BTG plc (BGC.L)
7/6/2011 11:07:40 AM
More...
|
Wellstat Therapeutics Corporation Investigational Drug Shows Life-Saving Potential In Treating Toxicity Of Widely Used Cancer Chemotherapy
5/22/2010 12:27:35 PM
More...
|
Sanofi (France) (SAN.PA) Buys Wellstat Therapeutics Corporation's Type II Diabetes Drug PN2034 For Up To $350 Million
10/21/2009 6:47:27 AM
More...
|
Wellstat Therapeutics Corporation's Chemotherapy Antidote May Be Lifesaving
5/19/2009 6:56:23 AM
More...
|
Wellstat Therapeutics Corporation Release: Investigational Drug Shows Promise as Treatment for Overexposure to Common Cancer Chemotherapy
5/15/2009 10:39:24 AM
More...
|